Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$134.56 - $217.97 $6,728 - $10,898
-50 Reduced 90.91%
5 $1,000
Q3 2021

Nov 09, 2021

BUY
$177.8 - $270.58 $4,445 - $6,764
25 Added 83.33%
55 $11,000
Q1 2021

May 14, 2021

SELL
$112.98 - $319.93 $18,641 - $52,788
-165 Reduced 84.62%
30 $5,000
Q4 2020

Feb 12, 2021

BUY
$78.74 - $139.5 $15,354 - $27,202
195 New
195 $22,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $662M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Bdo Wealth Advisors, LLC Portfolio

Follow Bdo Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdo Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bdo Wealth Advisors, LLC with notifications on news.